Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterNo recent work listed

Masanori Terashima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2967-8267; OpenAlex author ID A5026555298. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper

Papers 4

  1. Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients. Co-author DOI 10.1007/s00534-011-0457-7↗
  2. ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-g… Co-author DOI 10.1007/s10147-011-0197-3↗
  3. [Postoperative adjuvant treatment for pancreatic cancer]. Last author PMID 21688463↗
  4. [Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective]. Last author PMID 21918335↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hideyuki Kanemoto · 2 shared papers, 2011 · strength 0.06
  2. Teiichi Sugiura · 2 shared papers, 2011 · strength 0.06
  3. Katsuhiko Uesaka · 2 shared papers, 2011 · strength 0.06
  4. Atsushi Irisawa · 2 shared papers, 2011–2012 · strength 0.05
  5. Tadayuki J. Takagi · 2 shared papers, 2011–2012 · strength 0.05
  6. Hiromasa Ohira · 2 shared papers, 2011–2012 · strength 0.05
  7. Yukiyasu Okamura · 1 shared paper, 2011 · strength 0.03
  8. Hisahito Endo · 1 shared paper, 2012 · strength 0.03
  9. Mitsukazu Gotoh · 1 shared paper, 2012 · strength 0.03
  10. Takeru Wakatsuki · 1 shared paper, 2011 · strength 0.02
  11. Rei Suzuki · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.